Amino acid-derived diaminopropanols

Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

25218212, 560 27, 560 29, C07C20936

Patent

active

060639636

DESCRIPTION:

BRIEF SUMMARY
BACKGROUND OF THE INVENTION

The inhibition of various proteases has application in treating many medical conditions, such as Alzheimer's disease, retroviral infections, hypotension and hypertension. Many protease-inhibitor compounds have been identified. However, the methods for synthesizing these protease-inhibitor compounds are often complex and/or expensive. Consequently, methods are needed to produce protease-inhibitor compounds through simpler and/or less expensive processes.


SUMMARY OF THE INVENTION

The present invention relates to a method of forming a 1,3-diamino-3-substituted-2-propanol chemical intermediate represented by the following structural formula (structural formula I): ##STR1## and salts thereof, wherein R.sup.1 is a protecting group and R.sup.2 is selected from the group consisting of --H, C1-C18 alkyl, aryl, heteroaryl, acetyl and tosyl.
Additionally, R.sup.3 is the side-chain of an amino acid wherein the amino acid has the structural formula (structural formula II): ##STR2##
Some examples of suitable amino acids include natural and synthetic .alpha.-amino acids, such as alanine, cysteine, 3,5-dibromotyrosine, 3,5-diiodotyrosine, glutamine, glycine, histidine, hydroxylysine, isoleucine, leucine, methionine, phenylalanine, serine, threonine, thyroxine, tryptophane, tyrosine, valine and .alpha.-aminobutyric acid. In addition, wherein the amino acid has a chiral center, the side-chain may be from either the D or L isomer of the amino acid. Further, the amino acid may optionally be substituted with one or more substitutents, such as halogen, hydroxyl, sulfonate, C1-C3 alkyl, C1-C3 alkoxy and acyl.
Furthermore, R.sup.4 and R.sup.5 are each independently selected from the group consisting of --H, alkyl, aryl, nitrile and alkoxycarbonyl. However, it is preferred that R.sup.4 and R.sup.5 are not both alkoxycarbonyl groups.
This method includes contacting a nitromethyl amino acid compound with at least one reducing agent to form said chemical intermediate. A suitable nitromethyl amino acid compound is represented by the following structural formula (structural formula III): ##STR3## wherein R.sup.6 is either ##STR4##
The benefits of this invention include the ability to produce protease-inhibitor compounds, and other drugs, through simpler and/or less expensive synthetic processes.


DETAILED DESCRIPTION OF THE INVENTION

A chemical intermediate, as defined herein, comprises a compound from which various chemicals, such as selected protease-inhibitors and other drugs, as well as polymers, can be synthesized. In a preferred embodiment, the 1,3-diamino-3-substituted-2-propanol chemical intermediate is derived from phenylalanine and comprises a 1,3-diamino-3-benzyl-2-propanol compound.
Suitable protecting groups include protecting groups which generally prevent substitution or addition reactions from occurring with a protected amino group while producing said chemical intermediate according to the method of this invention. Examples of suitable protecting groups include benzyl, t-butyloxycarbonyl (Boc), benzyloxycarbonyl (Cbz), 9-fluorenylmethoxycarbonyl (f-moc), 2,2,2-trichloroethoxycarbonyl, 2-haloethoxycarbonyl, benzoyl, phthalimidyl, diphenylphosphinyl and benzenesulfonyl. Alternatively, R.sup.1 and R.sup.2 can be combined to form a protecting group, such as dibenzyl.
Alkyl groups of the present invention include straight-chained, branched and cyclic alkyl radicals containing up to about 18 carbons. Suitable alkyl groups may be saturated or unsaturated. Further, an alkyl group may also be substituted one or more times on one or more carbons with substitutents selected form the group consisting of C1-C6 alkyl, C3-C6 heterocycle, aryl, halo, hydroxy, amino, alkoxy and sulfonyl. Additionally, an alkyl group may contain up to 3 heteroatoms. Suitable heteroatoms include nitrogen, oxygen and sulfur.
Aryl groups of the present invention include aryl radicals which may optionally contain up to 3 heteroatoms. An aryl group may also be optionally substituted one or more times with an aryl group or a

REFERENCES:
patent: H725 (1990-01-01), Gordon
patent: 3197510 (1965-07-01), Cyba
patent: 4123462 (1978-10-01), Best
patent: 4604402 (1986-08-01), Godfrey, Jr. et al.
patent: 4692455 (1987-09-01), Gordon
patent: 4740508 (1988-04-01), Weller, III et al.
patent: 4749792 (1988-06-01), Natarajan et al.
patent: 5278148 (1994-01-01), Branca et al.
patent: 5616726 (1997-04-01), Mitsuda et al.
D. Tourwe, et al., "A New Method for the Solid Phase Synthesis of Hydroxyethylamine Peptide Bond Isosteres: Synthesis of an HIV-1 Protease Inhibitor and of a .beta.-Casomorphin-5 Analogue," Tetrahedron Letters 34(34) pp. 5499-5502 (1993).
D. C. Baker, and S. R. Putt, "C-Acylation of Nitromethane. A Synthetic Route to .alpha.-Nitroketones," Synthesis; Communications, 478-479 (Jun. 1978).
D. Brillion And G. Suave, "Silica Gel-Catalyzed Knoevenagel Condensation of Peptidyl Cyanomethyl Ketones with Aromatic Aldehydes and Ketons. A Novel Michael Acceptor Functionality for C-Modified Peptides: The Benzylidene and Alkylidene Cyanomethyl Ketone Function", J. Org. Chem 57: 1838-1842 (1992).
H. Sasai, et al., "Diasteroselectie Catalytic Asymmetric Nitroaldol Reaction Utilising Rare Earth Li-(R)-BINOL Complex. A Highly Efficient Synthesis of Norstatine", Tetrahedron Letters, 35(33): 6123-6126 (1994).
C. L. Lane, "Sodium Cyanoborohydride: A Highly Selective Reducing Agent," Selections from the Aldrichimica Acta (Aldrich-Boranes, Inc.) pp. 67-74 (1994).
T. Imai, et al., "Organoboron Compounds in Organic Synthesis. 2. Asymmetric Reduction-of-Diakyl Ketones with (R,R)-or (S,S)-2,5-Dimethylborolane," J. Am. Chem. Soc., 108:7402-7404 (1986).
E. J. Corey, et al., "A Stable and Easily Prepared Catlyst for the Enantioselective Reduction of Ketone. Applications to Multistep Syntheses," J. Am. Chem. Soc., 109:7925-7926 (1987).
H. C. Brown, et al., "Chiral Synthesis via Organoboranes. 15. Selectie Reductions. 42. Asymmetric Reduction of Representative Prochiral Ketones with Potassium 9-0-(1,2:5,6-Di-O-isopropylidine-.alpha.-D-glucofuranosyl)-9-boratabicyclo [3.3.1]-nonane," J. Org. Chem., 53:1231-1238 (1988).
A. G. M. Barrett, et al., "Transfer Hydrogenation: A Sterospecific Method for the Conversion of Nitro Alkanes into Amines," Tetrahedron Letters, 29(45):5733-5734 (1988).
A. Dondoni, et al., "Iterative, Stereoselective Homologation of Chiral Polyalkoxy Aldehydes Employing 2-(Trimethylsilyl)thiazole as a Formyl Anion Equivalent. The Thiazole Route to Higher Carbohydrates," J. Org. Chem., 54:693-702 (1989).
M. M. Midland, et al., "Asymmetric Reductions of Prochiral Ketones with Lithium [2-[(Benzyloxy)ethyl]-6,6-dimethylbicyclo[3.3.1]-3-nonyl]-9- boratabicyclo[3.3.1] nonane (Lithium NB-Enantride) and its Derivatives," J. Org. Chem., 56:1068-1074 (1991).
D.A. Evans, et al., "Synthetic Applications of Tremethylsilyl Cyanide. An Efficient Synthesis of .beta.-Aminomethyl Alcohols," J. Org. Chem., 39(7):914-917 (1974).
S. Ram and R. E. Ehrenkaufer, "A Facile Synthesis of .alpha.-Amino Esters Via Reduction of .alpha.-Nitro Esters Using Ammonium Formate as a Catalytic Hydrogen Transfer Agent," Synthesis; Communications, 133-135 (Feb. 1986).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Amino acid-derived diaminopropanols does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amino acid-derived diaminopropanols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid-derived diaminopropanols will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-260215

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.